Medical Devices Medical Specialties News Press

Europe Nasal Delivery Devices Market Forecast to 2027 – Covid-19 Impact and Global Analysis – By Drug Type (Anaesthetics,Antibiotics,Pain Relief Drugs,Calcium Supplements,Vasoconstrictors,Antihistamines,Others); By Delivery Technologies (Spray,Nebulizers,Inhalers,Others) Others and Geography

According to The Insight Partners market research study of ‘Europe Nasal Delivery Devices Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by drug type, delivery technologies, and end user’ the Europe nasal delivery devices market is expected to reach US$ 24,072.24 million in 2027 from US$ 15,140.36 in 2019. The market is estimated to grow with a CAGR of 6.0% from 2020-2027. The report provides trends prevailing in the Europe nasal delivery devices market and the factors driving market along with those that act as hindrances.

Based on the drug type, the Europe the nasal delivery devices market, is segmented into anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. The antihistamines segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. Antihistamines are drugs/ medication which is used in treatment of allergic rhinitis and other allergies. Several times people take antihistamines as an inexpensive, generic, over-the-counter drug that can provide relief from sneezing, nasal congestion, or hives caused by pollen, dust mites, or animal allergy with few side effects. The four intranasal histamine-1 receptor antagonist (H1-antihistamines) products that are approved for the management of rhinitis include azelastine (Astelin, Astepro), olopatadine (Patanase) and azelastine hydrochloride/fluticasone propionate (Dymista).

Request For Sample Reports @ https://www.theinsightpartners.com/sample/TIPRE00018195/

Company Profiles

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Reddy’s Laboratories

The growth of the market is attributed to some key driving factors such as the rising geriatric population and government initiatives and the increasing incidences of neurological disorders. However, the market growth is likely to be hindered owing to the concerns associated with nasal drug delivery market.

GlaxoSmithKline plc., AstraZeneca, Pfizer Inc. are among the leading companies operating in the Europe nasal delivery devices market.

EUROPE NASAL DELIVERY DEVICES MARKET SEGMENTATION

By Drug Type

  • Anaesthetics
  • Antibiotics
  • Pain Relief Drugs
  • Calcium Supplements
  • Vasoconstrictors
  • Antihistamines
  • Others

By Delivery Technologies

  • Spray
  • Nebulizers
  • Inhalers
  • Others

By End User

  • Home Care Settings
  • Hospitals
  • Clinics

By Country

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe

You Can Buy This Report from Here@ https://www.theinsightpartners.com/buy/TIPRE00018195/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.